Peplomycin induces G1-phase specific apoptosis in liver carcinoma cell line Bel-7402 involving G2-phase arrest. 2004

Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
College of Life Sciences, Wuhan University, Wuhan 430072, China.

OBJECTIVE To investigate the mechanism of peplomycin (PEP)-induced apoptosis in liver carcinoma cell line (Bel-7402). METHODS Growth inhibition by PEP was analyzed using 3- 4,5-Dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptotic cells were detected using Hoechest 33258 staining, and confirmed by flow cytometric analysis and DNA fragmentation analysis. The expression of cyclin A and B1 were determined by flow cytometry and Western blot. Annexin V assay was measured by flow cytometric analysis. RESULTS PEP induced apoptosis and then inhibited cell proliferation in liver carcinoma cell line Bel-7402. Cells treated with PEP 50 mumol/L for 15 h were arrested in G2-phase with dramatical expression of cyclin A and a little change in cyclin B1. Almost all the apoptosis occurred in cells undergoing the G1-phase after treatment for 24 h. CONCLUSIONS Peplomycin induced G1-phase specific apoptosis in Bel-7402 involving G2-phase arrest.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D016193 G1 Phase The period of the CELL CYCLE preceding DNA REPLICATION in S PHASE. Subphases of G1 include "competence" (to respond to growth factors), G1a (entry into G1), G1b (progression), and G1c (assembly). Progression through the G1 subphases is effected by limiting growth factors, nutrients, or inhibitors. First Gap Phase,G1a Phase,G1b Phase,Gap Phase 1,First Gap Phases,G1 Phases,G1a Phases,G1b Phases,Gap Phase, First,Gap Phases, First,Phase 1, Gap,Phase, First Gap,Phase, G1,Phase, G1a,Phase, G1b,Phases, First Gap,Phases, G1,Phases, G1a,Phases, G1b
D016195 G2 Phase The period of the CELL CYCLE following DNA synthesis (S PHASE) and preceding M PHASE (cell division phase). The CHROMOSOMES are tetraploid in this point. Gap Phase 2,Second Gap Phase,G2 Phases,Gap Phase, Second,Gap Phases, Second,Phase 2, Gap,Phase, G2,Phase, Second Gap,Phases, G2,Phases, Second Gap,Second Gap Phases
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017663 Peplomycin An antineoplastic agent derived from BLEOMYCIN. Pepleomycin,NK-631,Peplomycin Sulfate,Peplomycin Sulfate (1:1),NK 631,NK631,Sulfate, Peplomycin
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D019925 Cyclin A A cyclin subtype that has specificity for CDC2 PROTEIN KINASE and CYCLIN-DEPENDENT KINASE 2. It plays a role in progression of the CELL CYCLE through G1/S and G2/M phase transitions. Adenovirus E1A-Associated Protein p60,E1A p60,Type A Cyclin,Type A Cyclins,Adenovirus E1A Associated Protein p60,Cyclin, Type A,Cyclins, Type A

Related Publications

Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
October 2015, Toxicology in vitro : an international journal published in association with BIBRA,
Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
January 2008, The American journal of Chinese medicine,
Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
December 2015, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
September 2006, Onkologie,
Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
September 2015, Oncology letters,
Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
January 2015, The American journal of Chinese medicine,
Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
March 2015, Cell biochemistry and biophysics,
Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
August 2010, Cancer letters,
Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
July 2008, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Hong-ying Chen, and Cong-yi Zheng, and Guo-lin Zou, and Da-xing Xie, and Jian-ping Gong
January 2001, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Copied contents to your clipboard!